The fact that the A20ΔIECRipk1D138N/D138N mice still died at a later stage in our experiment may limit the enthusiasm for the potential use of RIPK1 inhibitors in IBD patients harboring A20 mutations. This evidence concerns the gene RIPK1 and inflammatory bowel disease.